Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2021 Results Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Amy Conrad - Investor Relations, Juniper Point Erik Holmlin - President and Chief Executive Officer Alka Chaubey - Chief Medical Officer Christopher Stewart - Chief Financial Officer Conference Call Participants Kevin DeGeeter - Oppenheimer & Co. Destiny Hance - Ladenburg Thalmann Michael Okunewitch - Maxim Group Operator Good day and welcome to the Bionano Genomics First Quarter 2021 E ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 | --- | --- | --- | |------------------------------------------------------------------------------------------------|------------------------------- ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2020 Earnings Conference Call March 23, 2021 4:30 PM ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - President and Chief Executive Officer Chris Stewart - Chief Financial Officer Conference Call Participants Kevin DeGeeter - Oppenheimer Jason McCarthy - Maxim Group Jeffrey Cohen - Ladenburg Thalmann Scott Henry - ROTH Capital Operator Good day, and welcome to the Bionano Genomics Fourth Quarter and Year-End 2020 Earnings Conference Call. At thi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM Commission File Number 001-38613 | --- | --- | |-----------------------------------------------------------------|--------------------------------------| | | | | B ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file numb ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2020 Results Conference Call November 12, 2020 4:30 PM ET Company Participants Ashley Robinson - IR Dr. Erik Holmlin - CEO Chris Stewart - CFO Conference Call Participants Kevin DeGeeter - Oppenheimer Jeffrey Cohen - Ladenburg Thalmann Scott Henry - ROTH Capital Operator Greetings. And welcome to Bionano Genomics Incorporated Third Quarter 2020 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the form ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q2 2020 Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants Ashley Robinson - LifeSci Advisors Erik Holmlin - Chief Executive Officer Conference Call Participants Kevin DeGeeter - Oppenheimer Adheip Mally - Maxim Group Operator Greetings. And welcome to Bionano Genomics Inc. Second Quarter 2020 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instru ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share BNGO The Nasdaq Stock Market, LLC Warrants to purchase Common Stock BNGOW The Nasdaq Stock Market, LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SE ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2020 Results Earnings Conference Call June 18, 2020 4:30 PM ET Company Participants Monique Kosse - Investor Relations Dr. Erik Holmlin - Chief Executive Officer Conference Call Participants Kevin DeGeeter - Oppenheimer Scott Henry - ROTH Capital Mike Okunewitch - Maxim Group Operator Greetings. And welcome to Bionano Genomics First Quarter 2020 Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow t ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share BNGO The Nasdaq Stock Market, LLC Warrants to purchase Common Stock BNGOW The Nasdaq Stock Market, LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SE ...